Crystal Sao Fong Cheung

Title: Innovations by Crystal Sao Fong Cheung

Introduction

Crystal Sao Fong Cheung is an accomplished inventor based in Bethesda, MD. She has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. With a total of three patents to her name, her work focuses on innovative solutions for cartilage disorders.

Latest Patents

Her latest patents include groundbreaking research on monoclonal antibodies that specifically bind to matrilin-3. These patents disclose not only the antibodies and their fragments but also conjugates that include these molecules. Additionally, the patents cover nucleic acid molecules encoding the antibodies and antigen-binding fragments. The disclosed methods aim to treat or inhibit cartilage disorders in subjects, including growth plate disorders such as skeletal dysplasia or short stature. The compositions developed from her research have the potential to significantly impact the treatment of these conditions.

Career Highlights

Crystal Cheung is currently affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this prestigious institution has allowed her to collaborate with leading experts in the field and contribute to important advancements in medical science.

Collaborations

Some of her notable coworkers include Jeffrey Baron and Julian Chun Kin Lui. Their collaborative efforts have further enhanced the research and development of innovative treatments in the biomedical field.

Conclusion

Crystal Sao Fong Cheung's contributions to the field of biomedical research through her patents on monoclonal antibodies represent a significant advancement in the treatment of cartilage disorders. Her work continues to inspire and pave the way for future innovations in healthcare.